MRKR - Marker Therapeutics, Inc.
1.16
-0.120 -10.345%
Share volume: 30,692
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$1.28
-0.12
-0.09%
Summary score
23%
Profitability
25%
Dept financing
5%
Liquidity
50%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-115.74%
Return on assets
-48.53%
Return on sales
0%
Return on invested capital
484.08%
Total debt ratio
26.3%
Debt ratio change over timeo
0%
Current Ratio
9.28%
Quick Ratio
0%
Cash Position Ratio
9.9%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.43%
Return on assets
-12.79%
Return on sales
0%
Return on invested capital
227.35%
Total debt ratio
12.13%
Debt ratio change over timeo
0%
Current Ratio
14.73%
Quick Ratio
0%
Cash Position Ratio
14.1%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-18.37%
Return on assets
-13.1%
Return on sales
0%
Return on invested capital
-72.23%
Total debt ratio
28.87%
Debt ratio change over time
0%
Current Ratio
6.97%
Quick Ratio
0%
Cash Position Ratio
6.45%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MRKR | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -115.74% | 17.45% | 4.69% | 19.89% |
| Return on assets | -48.53% | 3.37% | 3.35% | 11.41% |
| Return on sales | 0% | 23.96% | 25.96% | 42.05% |
| Return on invested capital | 484.08% | 5.2% | 4.37% | -272.99% |
| Profitability | 25% | 44% | 29% | 75% |
| Total debt ratio | 26.3% | 77% | 57.66% | 53.92% |
| Debt ratio change over time | 0% | 0% | 10.55% | 0% |
| Dept financing | 9% | 25% | 44% | 18% |
| Current Ratio | 14.73% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 14.1% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 24% | 31% | 20% |
| Short-term ratios | MRKR | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -14.43% | 44.06% | 6.24% | 17.3% |
| Return on assets | -12.79% | 3.88% | 3.22% | 9.33% |
| Return on sales | 0% | 27.04% | 24.93% | 40.02% |
| Return on invested capital | 227.35% | 9.69% | 4.96% | -224.06% |
| Profitability | 25% | 53% | 28% | 60% |
| Total debt ratio | 12.13% | 91.8% | 61.39% | 55.88% |
| Debt ratio change over time | 0% | 0% | 12.93% | 0% |
| Dept financing | 3% | 25% | 42% | 15% |
| Current Ratio | 14.73% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 14.1% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 24% | 28% | 21% |
